MedPath

河南立诺制药有限公司

Ownership
-
Established
2019-11-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Dapagliflozin Tablets

Product Name
达格列净片
Approval Number
国药准字H20253905
Approval Date
Apr 15, 2025
NMPA

Dapagliflozin Tablets

Product Name
达格列净片
Approval Number
国药准字H20253906
Approval Date
Apr 15, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.